Global Radiopharmaceuticals for Therapeutic Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

According to our (Global Info Research) latest study, the global Radiopharmaceuticals for Therapeutic market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Radiopharmaceuticals for Therapeutic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Radiopharmaceuticals for Therapeutic market size and forecasts, in consumption value ($ Million), 2018-2029
Global Radiopharmaceuticals for Therapeutic market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Radiopharmaceuticals for Therapeutic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Radiopharmaceuticals for Therapeutic market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radiopharmaceuticals for Therapeutic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radiopharmaceuticals for Therapeutic market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Novartis, China Isotope & Radiation, Dongcheng and Q BioMed, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Radiopharmaceuticals for Therapeutic market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Radium-223
    Lutetium-177
    Iodine-131
    Other

Market segment by Application
    Thyroid
    Bone Metastasis
    Lymphoma
    Other

Market segment by players, this report covers
    Bayer
    Novartis
    China Isotope & Radiation
    Dongcheng
    Q BioMed
    Curium Pharmaceuticals
    Jubilant DraxImage
    Lantheus
    Spectrum Pharmaceuticals
    Progenics Pharmaceuticals
    International Isotopes

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Radiopharmaceuticals for Therapeutic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radiopharmaceuticals for Therapeutic, with revenue, gross margin and global market share of Radiopharmaceuticals for Therapeutic from 2018 to 2023.
Chapter 3, the Radiopharmaceuticals for Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Radiopharmaceuticals for Therapeutic market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Radiopharmaceuticals for Therapeutic.
Chapter 13, to describe Radiopharmaceuticals for Therapeutic research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Radiopharmaceuticals for Therapeutic
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Radiopharmaceuticals for Therapeutic by Type
        1.3.1 Overview: Global Radiopharmaceuticals for Therapeutic Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type in 2022
        1.3.3 Radium-223
        1.3.4 Lutetium-177
        1.3.5 Iodine-131
        1.3.6 Other
    1.4 Global Radiopharmaceuticals for Therapeutic Market by Application
        1.4.1 Overview: Global Radiopharmaceuticals for Therapeutic Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Thyroid
        1.4.3 Bone Metastasis
        1.4.4 Lymphoma
        1.4.5 Other
    1.5 Global Radiopharmaceuticals for Therapeutic Market Size & Forecast
    1.6 Global Radiopharmaceuticals for Therapeutic Market Size and Forecast by Region
        1.6.1 Global Radiopharmaceuticals for Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Radiopharmaceuticals for Therapeutic Market Size by Region, (2018-2029)
        1.6.3 North America Radiopharmaceuticals for Therapeutic Market Size and Prospect (2018-2029)
        1.6.4 Europe Radiopharmaceuticals for Therapeutic Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size and Prospect (2018-2029)
        1.6.6 South America Radiopharmaceuticals for Therapeutic Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Radiopharmaceuticals for Therapeutic Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Radiopharmaceuticals for Therapeutic Product and Solutions
        2.1.4 Bayer Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Bayer Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Radiopharmaceuticals for Therapeutic Product and Solutions
        2.2.4 Novartis Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 China Isotope & Radiation
        2.3.1 China Isotope & Radiation Details
        2.3.2 China Isotope & Radiation Major Business
        2.3.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product and Solutions
        2.3.4 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 China Isotope & Radiation Recent Developments and Future Plans
    2.4 Dongcheng
        2.4.1 Dongcheng Details
        2.4.2 Dongcheng Major Business
        2.4.3 Dongcheng Radiopharmaceuticals for Therapeutic Product and Solutions
        2.4.4 Dongcheng Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Dongcheng Recent Developments and Future Plans
    2.5 Q BioMed
        2.5.1 Q BioMed Details
        2.5.2 Q BioMed Major Business
        2.5.3 Q BioMed Radiopharmaceuticals for Therapeutic Product and Solutions
        2.5.4 Q BioMed Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Q BioMed Recent Developments and Future Plans
    2.6 Curium Pharmaceuticals
        2.6.1 Curium Pharmaceuticals Details
        2.6.2 Curium Pharmaceuticals Major Business
        2.6.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Solutions
        2.6.4 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Curium Pharmaceuticals Recent Developments and Future Plans
    2.7 Jubilant DraxImage
        2.7.1 Jubilant DraxImage Details
        2.7.2 Jubilant DraxImage Major Business
        2.7.3 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Product and Solutions
        2.7.4 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Jubilant DraxImage Recent Developments and Future Plans
    2.8 Lantheus
        2.8.1 Lantheus Details
        2.8.2 Lantheus Major Business
        2.8.3 Lantheus Radiopharmaceuticals for Therapeutic Product and Solutions
        2.8.4 Lantheus Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Lantheus Recent Developments and Future Plans
    2.9 Spectrum Pharmaceuticals
        2.9.1 Spectrum Pharmaceuticals Details
        2.9.2 Spectrum Pharmaceuticals Major Business
        2.9.3 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Solutions
        2.9.4 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
    2.10 Progenics Pharmaceuticals
        2.10.1 Progenics Pharmaceuticals Details
        2.10.2 Progenics Pharmaceuticals Major Business
        2.10.3 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Solutions
        2.10.4 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Progenics Pharmaceuticals Recent Developments and Future Plans
    2.11 International Isotopes
        2.11.1 International Isotopes Details
        2.11.2 International Isotopes Major Business
        2.11.3 International Isotopes Radiopharmaceuticals for Therapeutic Product and Solutions
        2.11.4 International Isotopes Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 International Isotopes Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Radiopharmaceuticals for Therapeutic Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Radiopharmaceuticals for Therapeutic by Company Revenue
        3.2.2 Top 3 Radiopharmaceuticals for Therapeutic Players Market Share in 2022
        3.2.3 Top 6 Radiopharmaceuticals for Therapeutic Players Market Share in 2022
    3.3 Radiopharmaceuticals for Therapeutic Market: Overall Company Footprint Analysis
        3.3.1 Radiopharmaceuticals for Therapeutic Market: Region Footprint
        3.3.2 Radiopharmaceuticals for Therapeutic Market: Company Product Type Footprint
        3.3.3 Radiopharmaceuticals for Therapeutic Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Radiopharmaceuticals for Therapeutic Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Radiopharmaceuticals for Therapeutic Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2018-2023)
    5.2 Global Radiopharmaceuticals for Therapeutic Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2018-2029)
    6.2 North America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2018-2029)
    6.3 North America Radiopharmaceuticals for Therapeutic Market Size by Country
        6.3.1 North America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2018-2029)
        6.3.2 United States Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        6.3.3 Canada Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        6.3.4 Mexico Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Radiopharmaceuticals for Therapeutic Consumption Value by Type (2018-2029)
    7.2 Europe Radiopharmaceuticals for Therapeutic Consumption Value by Application (2018-2029)
    7.3 Europe Radiopharmaceuticals for Therapeutic Market Size by Country
        7.3.1 Europe Radiopharmaceuticals for Therapeutic Consumption Value by Country (2018-2029)
        7.3.2 Germany Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        7.3.3 France Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        7.3.5 Russia Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        7.3.6 Italy Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size by Region
        8.3.1 Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Region (2018-2029)
        8.3.2 China Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        8.3.3 Japan Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        8.3.4 South Korea Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        8.3.5 India Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        8.3.7 Australia Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2018-2029)
    9.2 South America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2018-2029)
    9.3 South America Radiopharmaceuticals for Therapeutic Market Size by Country
        9.3.1 South America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2018-2029)
        9.3.2 Brazil Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        9.3.3 Argentina Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country
        10.3.1 Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Country (2018-2029)
        10.3.2 Turkey Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)
        10.3.4 UAE Radiopharmaceuticals for Therapeutic Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Radiopharmaceuticals for Therapeutic Market Drivers
    11.2 Radiopharmaceuticals for Therapeutic Market Restraints
    11.3 Radiopharmaceuticals for Therapeutic Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Radiopharmaceuticals for Therapeutic Industry Chain
    12.2 Radiopharmaceuticals for Therapeutic Upstream Analysis
    12.3 Radiopharmaceuticals for Therapeutic Midstream Analysis
    12.4 Radiopharmaceuticals for Therapeutic Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Radiopharmaceuticals for Therapeutic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Radiopharmaceuticals for Therapeutic Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Radiopharmaceuticals for Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Radiopharmaceuticals for Therapeutic Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Bayer Company Information, Head Office, and Major Competitors
    Table 6. Bayer Major Business
    Table 7. Bayer Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 8. Bayer Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Bayer Recent Developments and Future Plans
    Table 10. Novartis Company Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 13. Novartis Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Novartis Recent Developments and Future Plans
    Table 15. China Isotope & Radiation Company Information, Head Office, and Major Competitors
    Table 16. China Isotope & Radiation Major Business
    Table 17. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 18. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. China Isotope & Radiation Recent Developments and Future Plans
    Table 20. Dongcheng Company Information, Head Office, and Major Competitors
    Table 21. Dongcheng Major Business
    Table 22. Dongcheng Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 23. Dongcheng Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Dongcheng Recent Developments and Future Plans
    Table 25. Q BioMed Company Information, Head Office, and Major Competitors
    Table 26. Q BioMed Major Business
    Table 27. Q BioMed Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 28. Q BioMed Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Q BioMed Recent Developments and Future Plans
    Table 30. Curium Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 31. Curium Pharmaceuticals Major Business
    Table 32. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 33. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Curium Pharmaceuticals Recent Developments and Future Plans
    Table 35. Jubilant DraxImage Company Information, Head Office, and Major Competitors
    Table 36. Jubilant DraxImage Major Business
    Table 37. Jubilant DraxImage Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 38. Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Jubilant DraxImage Recent Developments and Future Plans
    Table 40. Lantheus Company Information, Head Office, and Major Competitors
    Table 41. Lantheus Major Business
    Table 42. Lantheus Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 43. Lantheus Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Lantheus Recent Developments and Future Plans
    Table 45. Spectrum Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 46. Spectrum Pharmaceuticals Major Business
    Table 47. Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 48. Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Spectrum Pharmaceuticals Recent Developments and Future Plans
    Table 50. Progenics Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 51. Progenics Pharmaceuticals Major Business
    Table 52. Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 53. Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Progenics Pharmaceuticals Recent Developments and Future Plans
    Table 55. International Isotopes Company Information, Head Office, and Major Competitors
    Table 56. International Isotopes Major Business
    Table 57. International Isotopes Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 58. International Isotopes Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. International Isotopes Recent Developments and Future Plans
    Table 60. Global Radiopharmaceuticals for Therapeutic Revenue (USD Million) by Players (2018-2023)
    Table 61. Global Radiopharmaceuticals for Therapeutic Revenue Share by Players (2018-2023)
    Table 62. Breakdown of Radiopharmaceuticals for Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in Radiopharmaceuticals for Therapeutic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 64. Head Office of Key Radiopharmaceuticals for Therapeutic Players
    Table 65. Radiopharmaceuticals for Therapeutic Market: Company Product Type Footprint
    Table 66. Radiopharmaceuticals for Therapeutic Market: Company Product Application Footprint
    Table 67. Radiopharmaceuticals for Therapeutic New Market Entrants and Barriers to Market Entry
    Table 68. Radiopharmaceuticals for Therapeutic Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global Radiopharmaceuticals for Therapeutic Consumption Value (USD Million) by Type (2018-2023)
    Table 70. Global Radiopharmaceuticals for Therapeutic Consumption Value Share by Type (2018-2023)
    Table 71. Global Radiopharmaceuticals for Therapeutic Consumption Value Forecast by Type (2024-2029)
    Table 72. Global Radiopharmaceuticals for Therapeutic Consumption Value by Application (2018-2023)
    Table 73. Global Radiopharmaceuticals for Therapeutic Consumption Value Forecast by Application (2024-2029)
    Table 74. North America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
    Table 75. North America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
    Table 76. North America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. North America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. North America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
    Table 79. North America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
    Table 80. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
    Table 83. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
    Table 84. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
    Table 87. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
    Table 88. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
    Table 89. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
    Table 90. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
    Table 91. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Region (2024-2029) & (USD Million)
    Table 92. South America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
    Table 93. South America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
    Table 94. South America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
    Table 95. South America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
    Table 96. South America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. South America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
    Table 99. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
    Table 100. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
    Table 101. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
    Table 102. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
    Table 103. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
    Table 104. Radiopharmaceuticals for Therapeutic Raw Material
    Table 105. Key Suppliers of Radiopharmaceuticals for Therapeutic Raw Materials
List of Figures
    Figure 1. Radiopharmaceuticals for Therapeutic Picture
    Figure 2. Global Radiopharmaceuticals for Therapeutic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type in 2022
    Figure 4. Radium-223
    Figure 5. Lutetium-177
    Figure 6. Iodine-131
    Figure 7. Other
    Figure 8. Global Radiopharmaceuticals for Therapeutic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application in 2022
    Figure 10. Thyroid Picture
    Figure 11. Bone Metastasis Picture
    Figure 12. Lymphoma Picture
    Figure 13. Other Picture
    Figure 14. Global Radiopharmaceuticals for Therapeutic Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Radiopharmaceuticals for Therapeutic Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Radiopharmaceuticals for Therapeutic Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Region in 2022
    Figure 19. North America Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Radiopharmaceuticals for Therapeutic Revenue Share by Players in 2022
    Figure 25. Radiopharmaceuticals for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Radiopharmaceuticals for Therapeutic Market Share in 2022
    Figure 27. Global Top 6 Players Radiopharmaceuticals for Therapeutic Market Share in 2022
    Figure 28. Global Radiopharmaceuticals for Therapeutic Consumption Value Share by Type (2018-2023)
    Figure 29. Global Radiopharmaceuticals for Therapeutic Market Share Forecast by Type (2024-2029)
    Figure 30. Global Radiopharmaceuticals for Therapeutic Consumption Value Share by Application (2018-2023)
    Figure 31. Global Radiopharmaceuticals for Therapeutic Market Share Forecast by Application (2024-2029)
    Figure 32. North America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2018-2029)
    Figure 34. North America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2018-2029)
    Figure 40. Europe Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2018-2029)
    Figure 48. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2018-2029)
    Figure 57. South America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2018-2029)
    Figure 62. Middle East and Africa Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 66. Radiopharmaceuticals for Therapeutic Market Drivers
    Figure 67. Radiopharmaceuticals for Therapeutic Market Restraints
    Figure 68. Radiopharmaceuticals for Therapeutic Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Radiopharmaceuticals for Therapeutic in 2022
    Figure 71. Manufacturing Process Analysis of Radiopharmaceuticals for Therapeutic
    Figure 72. Radiopharmaceuticals for Therapeutic Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Companies Mentioned

Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes